SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO )
CNTO 0.000010000.0%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ibexx who wrote (924)5/3/1999 11:29:00 AM
From: Biomaven  Read Replies (2) of 965
 
Ibexx,

There certainly would be some premium over the current price. I would guess something like 25%, giving a price near $60.

Takeover speculation is not a good reason by itself to own a stock - too many things can happen to kill any particular takeover. However, in this case CNTO is still pretty cheap, and there are lots of possible suitors.

(BTW, Warner-Lambert is the company that bought Agouron, not J&J).

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News